Use of MRI, Metabolomic, and Genomic Biomarkers to Identify Mechanisms of Chemoresistance in Glioma

doi 10.20517/cdr.2019.18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OAE Publishing Inc.

Related search

Metabolomic Profiling to Identify Molecular Biomarkers of Cellular Response to Methotrexate in Vitro

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2019English

Biomarkers of Glioma

2011English

Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers

PLoS ONE
Multidisciplinary
2015English

Metabolomic Biomarkers: Search, Discovery and Validation

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2007English

Imaging Biomarkers in Oncology: Basics and Application to MRI

Journal of Magnetic Resonance Imaging
Nuclear MedicineRadiologyImaging
2018English

AKT/PKB Signaling Mechanisms in Cancer and Chemoresistance

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2005English

Use of MRI to Identify Enlarged Inferior Gluteal and Ischioanal Lymph Nodes and Associated Findings Related to the Primary Disease

Diagnostic and Interventional Radiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2016English

Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated With Prostate Cancer Risk

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2016English

Serological Proteomic Biomarkers to Identify Paracoccidioides Species and Risk of Relapse

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy